Periodic Review, Re-Validation and Lifecycle Management of GxP Systems Periodic Review, Re-Validation and Lifecycle Management of GxP Systems As the life sciences industry increasingly embraces digital transformation, the importance of maintaining compliance with regulatory standards becomes more critical. This regulatory explainer manual addresses the lifecycle management of Good Practice (GxP) systems, with a particular focus on the periodic review, re-validation, and compliance with the regulations outlined in 21 CFR Part 11, EU Annex 11, and associated guidelines. Understanding these aspects is essential for Regulatory Affairs (RA), Quality Assurance (QA), and clinical operation teams in ensuring data integrity and compliance in…

Integrating Cybersecurity, Backups and Disaster Recovery into CSV Scope Integrating Cybersecurity, Backups and Disaster Recovery into CSV Scope In the evolving landscape of pharmaceutical and biotech industries, the synchronization of digital systems with rigorous regulatory requirements is crucial. This article provides a comprehensive guide on integrating cybersecurity measures, backup processes, and disaster recovery plans into the Computerized System Validation (CSV) scope while aligning with the expectations set forth by regulatory authorities in the US, UK, and EU. Context The digitization of processes within the pharmaceutical industry has necessitated a stringent regulatory framework to ensure data integrity and compliance. Key regulations…

CSV Documentation Packages for Regulatory Submissions and Inspections CSV Documentation Packages for Regulatory Submissions and Inspections The integration of digital systems in pharmaceutical and biotech environments has become imperative in maintaining stringent quality and regulatory standards. In the context of Good Manufacturing Practices (GxP), the validation of computerized systems is essential to ensure compliance with defined regulations like 21 CFR Part 11 and EU Annex 11. This article serves as a comprehensive regulatory explainer manual on Computerized System Validation (CSV) specific to GxP applications, outlined in a structured approach for Regulatory Affairs (RA) professionals. Regulatory Context The reliance on computerized…

Risk Assessment Techniques for Prioritising CSV Scope and Testing Depth Risk Assessment Techniques for Prioritising CSV Scope and Testing Depth Context In the pharmaceutical and biotech sectors, regulatory compliance is paramount. Regulatory Affairs (RA) professionals face the challenge of ensuring that computerized systems used in Good Manufacturing Practice (GxP) environments are compliant with various regulations, including the U.S. Food and Drug Administration’s (FDA) 21 CFR Part 11, the European Union’s (EU) Annex 11, and guidelines from the Medicines and Healthcare products Regulatory Agency (MHRA). One of the critical components of maintaining compliance is the Computerised System Validation (CSV) process, a…

Agile, DevOps and Frequent Releases: Rethinking CSV Approaches Agile, DevOps and Frequent Releases: Rethinking CSV Approaches Context of Regulatory Affairs in GxP Applications In the rapidly evolving pharmaceutical and biotechnology industries, the integration of Agile methodologies and DevOps practices poses unique challenges and opportunities, particularly regarding Computerized System Validation (CSV) for Good Practice (GxP) applications. Regulatory Affairs (RA) professionals must navigate a complex landscape of compliance, including 21 CFR Part 11 in the US, EU Annex 11 requirements, and general GxP digital systems validation, when evaluating how to implement these new approaches while ensuring data integrity and regulatory compliance. Legal…

Automating CSV Evidence Collection and Test Execution Where It Makes Sense Automating CSV Evidence Collection and Test Execution Where It Makes Sense Regulatory Affairs Context for Computerised System Validation (CSV) In the rapidly evolving pharmaceutical and biotechnology sectors, ensuring compliance with regulations governing digital systems and data integrity is paramount. Regulatory Affairs (RA) professionals must navigate a complex web of requirements, including 21 CFR Part 11 in the US, EU Annex 11 requirements, and guidelines set forth by regulatory bodies such as the FDA, EMA, and MHRA. These regulations outline the expectations for computerised systems used in GxP environments, specifically…

Training IT and Business Owners on Their Roles in CSV Training IT and Business Owners on Their Roles in CSV Regulatory Affairs Context In the pharmaceutical and biotech industries, ensuring compliance with regulatory standards is paramount. This compliance encompasses not only product development and safety but extends to technical and operational aspects such as computerized systems. As regulatory requirements evolve, so do the roles of various stakeholders in the system validation process. Among these, Information Technology (IT) and business owners play a critical role in maintaining compliance with 21 CFR Part 11 and related regulations. Understanding their responsibilities within the…

Template Libraries for Validation Plans, URSs, IQ/OQ/PQ and Trace Matrices Template Libraries for Validation Plans, URSs, IQ/OQ/PQ and Trace Matrices Context The regulatory landscape for pharmaceutical and biopharmaceutical industries has evolved significantly with the advent of digital systems and the need for rigorous validation processes. Regulatory Affairs (RA) professionals play a crucial role in ensuring that computerized systems used in Good Practice (GxP) environments comply with relevant guidelines and regulations such as 21 CFR Part 11 in the US and EU Annex 11 Requirements. This document serves as a comprehensive regulatory explainer manual focused on the establishment and use of…

Leveraging GAMP 5 Second Edition and Industry Guidance for CSV Leveraging GAMP 5 Second Edition and Industry Guidance for CSV In the realm of pharmaceutical regulatory consulting, understanding the complexities surrounding Computerised System Validation (CSV) is essential for compliance with regulatory standards such as 21 CFR Part 11 and EU Annex 11. This article explores the pertinent regulations, guidelines, and agency expectations that govern CSV for GxP applications, providing essential insights for Regulatory Affairs, CMC, and Labelling teams operating in the US, EU, and UK markets. Context The increasing reliance on digital systems in the pharmaceutical industry necessitates a robust…

Future of CSV: From Validation to Computer Software Assurance (CSA) Future of CSV: From Validation to Computer Software Assurance (CSA) Context In the ever-evolving landscape of the pharmaceutical industry, the significance of Computerised System Validation (CSV) cannot be overstated. As technologies advance, regulatory frameworks are adapting to ensure data integrity and compliance with Good Automated Manufacturing Practice (GxP) standards. The transition from traditional validation practices to a more holistic approach known as Computer Software Assurance (CSA) is shaping the future of pharmaceutical regulatory consulting. This manual aims to delineate the current expectations regarding CSV, the legal and regulatory basis underlying…